SENS vs UNH

Senseonics (SENS) demonstrates strong operational execution with 87% YoY revenue growth in Q1 2026 and a strategic shift to direct European sales, strengthening its long-term competitive position. The unique 1-year Eversense sensor offers a significant market opportunity in the CGM space. However, the company continues to incur substantial net losses ($32.3M in Q1) and heavy cash burn. While recen...

UnitedHealth Group (UNH) remains a robust, high-quality mega-cap in the mature and highly regulated healthcare sector. Q1 2026 adjusted EPS of $7.23, a recent dividend increase to $2.32, and some analyst upgrades (e.g., Truist to $440, Goldman Sachs Conviction Buy) reflect solid operational performance and financial strength. However, these are characteristics of a stable compounder, not a company...